CEP55 was also negatively correlated with the clinical outcome in multiple human tumors, including liver cancer [43], non-small cell lung cancer [44], esophageal squamous cell carcinoma [45], and ovarian epithelial carcinoma [46]. The gene discussed is CEP55; the disease is liver cancer.